HU9501935D0 - Indole derivatives as steroid 5-alpha-reductase inhibitors - Google Patents

Indole derivatives as steroid 5-alpha-reductase inhibitors

Info

Publication number
HU9501935D0
HU9501935D0 HU9501935A HU9501935A HU9501935D0 HU 9501935 D0 HU9501935 D0 HU 9501935D0 HU 9501935 A HU9501935 A HU 9501935A HU 9501935 A HU9501935 A HU 9501935A HU 9501935 D0 HU9501935 D0 HU 9501935D0
Authority
HU
Hungary
Prior art keywords
pct
steroid
alpha
reductase inhibitors
indole derivatives
Prior art date
Application number
HU9501935A
Other languages
English (en)
Inventor
Julian Blagg
Graham Nigel Maw
David James Rawson
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939311008A external-priority patent/GB9311008D0/en
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of HU9501935D0 publication Critical patent/HU9501935D0/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
HU9501935A 1993-05-28 1994-05-26 Indole derivatives as steroid 5-alpha-reductase inhibitors HU9501935D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311008A GB9311008D0 (en) 1993-05-28 1993-05-28 Indoles
GB939317529A GB9317529D0 (en) 1993-05-28 1993-08-20 Indoles

Publications (1)

Publication Number Publication Date
HU9501935D0 true HU9501935D0 (en) 1995-09-28

Family

ID=26302960

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9501935A HU9501935D0 (en) 1993-05-28 1994-05-26 Indole derivatives as steroid 5-alpha-reductase inhibitors

Country Status (14)

Country Link
US (2) US5696146A (hu)
EP (1) EP0700395B1 (hu)
JP (1) JP2757969B2 (hu)
AT (1) ATE154352T1 (hu)
AU (1) AU6930494A (hu)
CA (1) CA2163778C (hu)
DE (1) DE69403793T2 (hu)
DK (1) DK0700395T3 (hu)
ES (1) ES2102863T3 (hu)
FI (1) FI113864B (hu)
GR (1) GR3024366T3 (hu)
HU (1) HU9501935D0 (hu)
IL (1) IL109728A0 (hu)
WO (1) WO1994027990A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
BRPI0719835A2 (pt) 2006-10-02 2014-05-06 Cortendo Invest Ab Enantiômero de cetoconazol em humanos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
EP0700395A1 (en) 1996-03-13
IL109728A0 (en) 1994-08-26
DE69403793D1 (de) 1997-07-17
US5922747A (en) 1999-07-13
CA2163778A1 (en) 1994-12-08
JPH08506350A (ja) 1996-07-09
FI113864B (fi) 2004-06-30
DE69403793T2 (de) 1997-09-25
EP0700395B1 (en) 1997-06-11
DK0700395T3 (da) 1997-10-13
FI955707A0 (fi) 1995-11-27
US5696146A (en) 1997-12-09
ES2102863T3 (es) 1997-08-01
GR3024366T3 (en) 1997-11-28
AU6930494A (en) 1994-12-20
WO1994027990A1 (en) 1994-12-08
FI955707A (fi) 1995-11-27
ATE154352T1 (de) 1997-06-15
CA2163778C (en) 1999-04-27
JP2757969B2 (ja) 1998-05-25

Similar Documents

Publication Publication Date Title
ES2149208T3 (es) Inhibidores 4-azaesteroides de 5-alfa-reductasa.
AU5711594A (en) Piperazine derivatives as 5-ht antagonists
HU9402466D0 (en) Indole derivatives as steroid-5-alpha-reductase inhibitors
GR3021736T3 (en) N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc.
HU9501935D0 (en) Indole derivatives as steroid 5-alpha-reductase inhibitors
PL313037A1 (en) Phenoxphenylocyclopententenylohydroxyureas
ZA938414B (en) Substituted ortho-ethenylphenylacetic acid derivatives
DE69405760T2 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
YU31502A (sh) Kristali kao inhibitori natrijum-vodonik izmenjivača tip1
ATE206127T1 (de) Inhibitoren retroviraler proteasen